270773

Drug Profile

270773

Alternative Names: GR 270773; GR 270773 Emulsion; GR 270773X

Latest Information Update: 25 Jan 2007

Price : $50

At a glance

  • Originator Sepsicure
  • Class Antibacterials
  • Mechanism of Action Endotoxin inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Sepsis; Septic shock

Most Recent Events

  • 24 Jan 2006 Data presented at the 45th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC-2005) have been added to the drug interactions section
  • 31 Dec 2003 Phase-II clinical trials in Sepsis in United Kingdom (unspecified route)
  • 31 Dec 2003 Phase-II clinical trials in Septic shock in United Kingdom (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top